DocuSign, Inc. (DOCU) stock
DOCUNasdaqServices-Prepackaged SoftwareFiscal year ends January 31
Financials through Q2 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 4, 2026Score 12/3029% above fair value
$80.76+0.61 (+0.76%)
Close on Nov 13, 2026Market cap $15.09BP/E 49.2Yield –
DocuSign r&d expenses
Research and development expenses are spending on new products and technology.
DocuSign's R&D Expenses for the twelve months ending Jul 31, 2026 was $659.08M, up 3.7% year over year. For fiscal 2026 it was $664.99M, up 13.0% from the year before. The highest annual figure on record is $664.99M in fiscal 2026.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jan 31, 2026 | $664.99M | +13.0% |
| FY2025 | Jan 31, 2025 | $588.46M | +9.1% |
| FY2024 | Jan 31, 2024 | $539.49M | +12.3% |
| FY2023 | Jan 31, 2023 | $480.58M | +22.2% |
| FY2022 | Jan 31, 2022 | $393.36M | +44.9% |
| FY2021 | Jan 31, 2021 | $271.52M | +46.3% |
| FY2020 | Jan 31, 2020 | $185.55M | -0.2% |
| FY2019 | Jan 31, 2019 | $185.97M | +101.2% |
| FY2018 | Jan 31, 2018 | $92.43M | +3.1% |
| FY2017 | Jan 31, 2017 | $89.65M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2027CQ2 2026 | Jul 31, 2026 | $163.58M | -3.6% |
| Q1 FY2027CQ1 2026 | Apr 30, 2026 | $159.59M | +0.1% |
| Q4 FY2026CQ4 2025 | Jan 31, 2026 | $168.28M | +8.2% |
| Q3 FY2026CQ3 2025 | Oct 31, 2025 | $167.63M | +10.9% |
| Q2 FY2026CQ2 2025 | Jul 31, 2025 | $169.63M | +14.9% |
| Q1 FY2026CQ1 2025 | Apr 30, 2025 | $159.45M | +18.7% |
| Q4 FY2025CQ4 2024 | Jan 31, 2025 | $155.46M | +2.6% |
| Q3 FY2025CQ3 2024 | Oct 31, 2024 | $151.10M | +10.6% |
| Q2 FY2025CQ2 2024 | Jul 31, 2024 | $147.57M | +8.5% |
| Q1 FY2025CQ1 2024 | Apr 30, 2024 | $134.32M | +16.4% |
| Q4 FY2024CQ4 2023 | Jan 31, 2024 | $151.52M | +20.4% |
| Q3 FY2024CQ3 2023 | Oct 31, 2023 | $136.64M | +17.9% |
| Q2 FY2024CQ2 2023 | Jul 31, 2023 | $135.96M | +7.5% |
| Q1 FY2024CQ1 2023 | Apr 30, 2023 | $115.36M | +2.8% |
| Q4 FY2023CQ4 2022 | Jan 31, 2023 | $125.89M | +13.7% |
| Q3 FY2023CQ3 2022 | Oct 31, 2022 | $115.93M | +13.0% |
| Q2 FY2023CQ2 2022 | Jul 31, 2022 | $126.53M | +33.7% |
| Q1 FY2023CQ1 2022 | Apr 30, 2022 | $112.23M | +31.4% |
| Q4 FY2022CQ4 2021 | Jan 31, 2022 | $110.69M | +38.1% |
| Q3 FY2022CQ3 2021 | Oct 31, 2021 | $102.60M | +39.9% |
| Q2 FY2022CQ2 2021 | Jul 31, 2021 | $94.65M | +48.4% |
| Q1 FY2022CQ1 2021 | Apr 30, 2021 | $85.42M | +57.5% |
| Q4 FY2021CQ4 2020 | Jan 31, 2021 | $80.14M | +53.8% |
| Q3 FY2021CQ3 2020 | Oct 31, 2020 | $73.36M | +50.5% |
| Q2 FY2021CQ2 2020 | Jul 31, 2020 | $63.79M | +34.2% |
| Q1 FY2021CQ1 2020 | Apr 30, 2020 | $54.23M | +45.9% |
| Q4 FY2020CQ4 2019 | Jan 31, 2020 | $52.09M | +21.4% |
| Q3 FY2020CQ3 2019 | Oct 31, 2019 | $48.76M | +27.0% |
| Q2 FY2020CQ2 2019 | Jul 31, 2019 | $47.52M | +40.7% |
| Q1 FY2020CQ1 2019 | Apr 30, 2019 | $37.18M | -47.5% |
| Q4 FY2019CQ4 2018 | Jan 31, 2019 | $42.92M | +83.2% |
| Q3 FY2019CQ3 2018 | Oct 31, 2018 | $38.40M | +70.5% |
| Q2 FY2019CQ2 2018 | Jul 31, 2018 | $33.77M | +42.1% |
| Q1 FY2019CQ1 2018 | Apr 30, 2018 | $70.87M | +212.1% |
| Q4 FY2018CQ4 2017 | Jan 31, 2018 | $23.43M | – |
| Q3 FY2018CQ3 2017 | Oct 31, 2017 | $22.52M | – |
| Q2 FY2018CQ2 2017 | Jul 31, 2017 | $23.77M | – |
| Q1 FY2018CQ1 2017 | Apr 30, 2017 | $22.71M | – |
See a number that looks wrong?